{"DataElement":{"publicId":"2925066","version":"1","preferredName":"Head and Neck Tumor Clinical Stage Grouping Stage","preferredDefinition":"the clinical stage grouping, an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage of a malignant neoplasm a benign or malignant neoplasm affecting one of the following areas: base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","longName":"2925063v1.0:2925064v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2925063","version":"1","preferredName":"Head and Neck Tumor Clinical Stage Grouping","preferredDefinition":"information related to the clinical stage grouping, an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage of a malignant neoplasm located in the head and neck.","longName":"2228482v1.0:2925061v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2228482","version":"1","preferredName":"Head and Neck Neoplasm","preferredDefinition":"For oncology, area of the body generally construed to comprise base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12418:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck","conceptCode":"C12418","definition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6EF4E2B-72AC-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-12","modifiedBy":"ONEDATA","dateModified":"2005-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2925061","version":"1","preferredName":"Clinical Stage Grouping","preferredDefinition":"Having to do with the examination and treatment of patients.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25398:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-281E-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-282F-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2925064","version":"1","preferredName":"Head and Neck Neoplasm Stage Grouping Stage","preferredDefinition":"the stage grouping, based on the T, N, M staging system, for a benign or malignant neoplasm affecting one of the following areas: base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","longName":"2925064v1.0","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage I","valueDescription":"Stage I Head and Neck cancer","ValueMeaning":{"publicId":"2922663","version":"1","preferredName":"Stage I Head and Neck cancer","longName":"2922663","preferredDefinition":"Tumor 2 centimeters or less in size at the greatest dimension","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FA35E68-70CA-1EF4-E040-BB89AD437B27","latestVersionIndicator":"Yes","beginDate":"2009-07-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FD8E36A-28CB-6D78-E040-BB89AD43144A","beginDate":"2009-07-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Stage II Head and Neck cancer","ValueMeaning":{"publicId":"2922662","version":"1","preferredName":"Stage II Head and Neck cancer","longName":"2922662","preferredDefinition":"Tumor larger than 2 centimeters but less than 4 centimeters at greatest dimension; no evidence of nodal or distant disease.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FA35E68-70A7-1EF4-E040-BB89AD437B27","latestVersionIndicator":"Yes","beginDate":"2009-07-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FD8E36A-28DF-6D78-E040-BB89AD43144A","beginDate":"2009-07-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Stage III Head and Neck cancer","ValueMeaning":{"publicId":"2922661","version":"1","preferredName":"Stage III Head and Neck cancer","longName":"2922661","preferredDefinition":"Tumor larger than 4 centimeters with or without evidence of lymph nodes smaller than 3 centimeters.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FA35E68-7084-1EF4-E040-BB89AD437B27","latestVersionIndicator":"Yes","beginDate":"2009-07-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FD8E36A-28F3-6D78-E040-BB89AD43144A","beginDate":"2009-07-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":"Stage IV Head and Neck cancer","ValueMeaning":{"publicId":"2922660","version":"1","preferredName":"Stage IV Head and Neck cancer","longName":"2922660","preferredDefinition":"Tumor any size, with nodal disease and/or evidence of distant metastases","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FA35E68-7061-1EF4-E040-BB89AD437B27","latestVersionIndicator":"Yes","beginDate":"2009-07-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-07-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6FD8E36A-2907-6D78-E040-BB89AD43144A","beginDate":"2009-07-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","deletedIndicator":"No"},{"value":"Stage IVC","valueDescription":"Stage IVC","ValueMeaning":{"publicId":"3479264","version":"1","preferredName":"Stage IVC","longName":"3479264","preferredDefinition":"Distant metastatic disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26FC1C4-CFC8-B22A-E040-BB89AD4340E4","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C26FC1C4-CFE0-B22A-E040-BB89AD4340E4","beginDate":"2012-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-14","modifiedBy":"ONEDATA","dateModified":"2012-06-14","deletedIndicator":"No"},{"value":"Stage IVB","valueDescription":"Stage IVB","ValueMeaning":{"publicId":"3479265","version":"1","preferredName":"Stage IVB","longName":"3479265","preferredDefinition":"Very advanced local/regional disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26FC1C4-CFEB-B22A-E040-BB89AD4340E4","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C26FC1C4-D003-B22A-E040-BB89AD4340E4","beginDate":"2012-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-14","modifiedBy":"ONEDATA","dateModified":"2012-06-14","deletedIndicator":"No"},{"value":"Stage IVA","valueDescription":"Stage IVA","ValueMeaning":{"publicId":"3479266","version":"1","preferredName":"Stage IVA","longName":"3479266","preferredDefinition":"Moderately advanced local/regional disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C26FC1C4-D00E-B22A-E040-BB89AD4340E4","latestVersionIndicator":"Yes","beginDate":"2012-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C26FC1C4-D026-B22A-E040-BB89AD4340E4","beginDate":"2012-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-14","modifiedBy":"ONEDATA","dateModified":"2012-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2428501","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"053C2A34-089B-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-28AC-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"CAMPBELB","dateModified":"2012-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[{"name":"caBIG","type":"USED_BY","context":"NCIP"},{"name":"2925063v1.0:2925064v1.0","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Clinical Stage","type":"Preferred Question Text","description":"Clinical Stage","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Stage of primary disease","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Stage at initial diagnosis","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-2911-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"TSESU","dateModified":"2018-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}